The role of blinatumomab in ALL
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results
iwNHL 2016: Highlights from Day 1
Catherine Bollard et al.
Comparing continuous and fixed duration myeloma treatment with triplets and doublets
Comparing ibrutinib efficacy and toxicity levels by age for patients with CLL/SLL